AlenCiken

Granted FDA Emergency Use Authorization

NASDAQ:FLDM   None
Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19

-Easy-to-Administer Saliva Test for COVID-19 Available for Immediate Shipment

-Extraction-Free, Real-Time PCR Workflow with Capacity of up to 6,000 Tests per Day per System

-Demonstrated 100 Percent Agreement with Authorized Nasopharyngeal Assays

finance.yahoo.com/ne...ation-030000078.html

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.